muscimol has been researched along with 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bak, HR; Cheong, JH; Jeon, SJ; Kim, GH; Ko, KH; Lee, SH; Lee, YS; Rhee, SY; Ryu, JH; Seo, JE; Shin, CY | 1 |
1 other study(ies) available for muscimol and 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one
Article | Year |
---|---|
Oroxylin A increases BDNF production by activation of MAPK-CREB pathway in rat primary cortical neuronal culture.
Topics: Analysis of Variance; Animals; Bicuculline; Brain-Derived Neurotrophic Factor; Calcium; Cells, Cultured; Cerebral Cortex; CREB-Binding Protein; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Flavonoids; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Mitogen-Activated Protein Kinase Kinases; Models, Biological; Muscimol; Neurons; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Sodium Channel Blockers; Tetrodotoxin; Time Factors | 2011 |